Presentation Information
[P-42]Development of a Novel CRISPR-Cas3-Based Therapeutic Strategy for the Eradication of HBV DNA
*Yoshiki Saiki1, Kazuto Yoshimi2, Masahiko Ito3, Tetsuro Suzuki3, Tomoji Mashimo1 (1. Department of Animal Genetics, The UTOPIA Center, The University of Tokyo (Japan), 2. Laboratory Animal Science, Graduate School of Medicine and Faculty of Medicine, Kyoto University (Japan), 3. Department of Microbiology and Immunology, Hamamatsu University School of Medicine (Japan))
Keywords:
genome editing,gene therapy,Hepatitis B virus
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in